Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6404986
Reference Type
Journal Article
Title
Final height in Italian patients with congenital hypothyroidism detected by neonatal screening: a 20-year observational study
Author(s)
Delvecchio, M; Vigone, MC; Wasniewska, M; Weber, G; Lapolla, R; Popolo, PP; Tronconi, GM; Di Mase, R; De Luca, F; Cavallo, L; Salerno, M; Faienza, MF
Year
2015
Volume
41
Page Numbers
82
Language
English
PMID
26511640
DOI
10.1186/s13052-015-0190-y
Web of Science Id
WOS:000363999800002
Abstract
BACKGROUND:
Linear growth and final height are reported as normal in congenital hypothyroid patients in the neonatal screening era.
METHODS:
We evaluated the final height in 215 patients with congenital hypothyroidism to assess if it improved over the last 2 decades.
RESULTS:
Final height (-0.1 ± 1.0 SDS) was higher than target height (-0.8 ± 1.0 SDS, p < 0.001) and not different among the 4 quartiles for birthdate. It was correlated with target height (r(2) = 0.564, p < 0.001) and height at puberty onset (r(2) = 0.685, p < 0.001), but not with age at diagnosis or the starting LT4/kg/day dose. The curve fitting analysis showed that the age at diagnosis progressively decreased during the 20-year study period, while the target height and the starting LT4/kg/day increased. Final height was not affected by the birthdate, the age at diagnosis, the starting LT4 dose.
CONCLUSIONS:
The final height is higher than the target height, but despite the improvement in the screening and the treatment, it did not improve over the last 20 years. These findings are in keeping with the described secular trend and suggest that earlier diagnosis and replacement therapy do not significantly modify final height in these patients.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity